Aleks Engel, a Novo partner and Repair Impact Fund director, will work with the firm’s bioindustrial team to accelerate sustainability.
Aleks Engel has joined the bioindustrials division of Novo Holdings, an investment arm of Denmark-based pharmaceutical conglomerate Novo Nordisk.
Engel’s stint at Novo Holdings began in 2014 when he joined as a director of principal investments. He was promoted to partner at the corporate’s life science investment group, Novo Seeds, four years later.
In his partner role, Engel simultaneously led the company’s $165m…
